Free Trial
CVE:PTF

Pender Growth Fund (PTF) Stock Price, News & Analysis

Pender Growth Fund logo
C$14.74 +0.04 (+0.27%)
As of 08/22/2025 02:06 PM Eastern

About Pender Growth Fund Stock (CVE:PTF)

Key Stats

Today's Range
C$14.74
C$14.77
50-Day Range
C$10.76
C$15.05
52-Week Range
C$9.29
C$15.30
Volume
12,436 shs
Average Volume
3,194 shs
Market Capitalization
C$106.87 million
P/E Ratio
2.38
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PTF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pender Growth Fund and its competitors with MarketBeat's FREE daily newsletter.

PTF Stock News Headlines

Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.tc pixel
See More Headlines

PTF Stock Analysis - Frequently Asked Questions

Pender Growth Fund's stock was trading at C$11.19 on January 1st, 2025. Since then, PTF stock has increased by 31.7% and is now trading at C$14.74.

Shares of PTF stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Pender Growth Fund investors own include Armata Pharmaceuticals (ARMP), BioCardia (BCDA), Bristol Myers Squibb (BMY), Range Cancer Therapeutics ETF (CNCR), Inovio Pharmaceuticals (INO), Insight Select Income Fund (INSI) and Protalix BioTherapeutics (PLX).

Industry, Sector and Symbol

Stock Exchange
CVE
Industry
Asset Management
Sub-Industry
N/A
Current Symbol
CVE:PTF
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
C$6.20
Trailing P/E Ratio
2.38
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
C$44.92 million
Net Margins
90.98%
Pretax Margin
N/A
Return on Equity
49.26%
Return on Assets
25.87%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
51.12

Sales & Book Value

Annual Sales
C$49.38 million
Price / Sales
2.16
Cash Flow
C$1.77 per share
Price / Cash Flow
8.35
Book Value
C$15.08 per share
Price / Book
0.98

Miscellaneous

Outstanding Shares
7,250,430
Free Float
N/A
Market Cap
C$106.87 million
Optionable
Not Optionable
Beta
0.56
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (CVE:PTF) was last updated on 8/23/2025 by MarketBeat.com Staff
From Our Partners